Challenges, Shared Decision Making and Health Equity in Hemophilia and Real-World Patient Experience with HYMPAVZI (marstacimab-hncq)

Friday, April 25, 1:00pm - 2:00pm (CDT)

Time shown in-05:00 America, Chicago

To educate attendees on challenges, shared decision making and health equity in hemophilia and introduce HYMPAVZI pen, dosage, administration, and real-world patient experience with HYMPAVZI.
___________________

*HYMPAVZI is a TFPI antagonist.
Hympavzi is a trademark of Pfizer Inc.

Add to Calendar 2025/04/25 14:00:00 2025/04/25 15:00:00 America/New_York Challenges, Shared Decision Making and Health Equity in Hemophilia and Real-World Patient Experience with HYMPAVZI (marstacimab-hncq) To educate attendees on challenges, shared decision making and health equity in hemophilia and introduce HYMPAVZI pen, dosage, administration, and real-world patient experience with HYMPAVZI.
___________________

*HYMPAVZI is a TFPI antagonist.
Hympavzi is a trademark of Pfizer Inc. https://www.pfizerhemophiliawebinars.com/ false MM/DD/YYYY 30 OPAQUE avZuWStRUzjHnaTENmGz88174

https://www.pfizerhemophiliawebinars.com/